[go: up one dir, main page]

WO1992004469A3 - Procede de detection d'acide nucleique utilisant l'agglutination de particules - Google Patents

Procede de detection d'acide nucleique utilisant l'agglutination de particules Download PDF

Info

Publication number
WO1992004469A3
WO1992004469A3 PCT/GB1991/001517 GB9101517W WO9204469A3 WO 1992004469 A3 WO1992004469 A3 WO 1992004469A3 GB 9101517 W GB9101517 W GB 9101517W WO 9204469 A3 WO9204469 A3 WO 9204469A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
particle reagent
detection method
agglutination
acid detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1991/001517
Other languages
English (en)
Other versions
WO1992004469A2 (fr
Inventor
Allen Frank Giles
Karie Joanne Booth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of WO1992004469A2 publication Critical patent/WO1992004469A2/fr
Publication of WO1992004469A3 publication Critical patent/WO1992004469A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6862—Ligase chain reaction [LCR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Procédé servant à détecter la présence de séquences d'acide nucléique par agglutination d'un réactif à particules génériques. Les procédés connus nécessitent un réactif à particules spécifiques pour chaque séquence devant être détectée. En présence d'une séquence d'acide nucléique donnée, une espèce d'acide nucléique, comprenant au moins deux partenaires de liaison, est produite. Le réactif à particules génériques est recouvert par un partenaire de liaison spécifique qui peut se lier aux partenaires de liaison de l'espèce d'acide nucléique et permet ainsi l'agglutination de la particule. Le procédé peut aussi être utilisé pour détecter des mutations dans une séquence d'acide nucléique. Un mode préféré de réalisation utilise un haptène tel que de la fluorescéine comme partenaire de liaison dans l'espèce d'acide nucléique et des particules recouvertes d'un anticorps anti-haptène tel que du latex recouvert d'un anticorps anti-fluorescéine comme le reáctif à particules génériques.
PCT/GB1991/001517 1990-09-06 1991-09-06 Procede de detection d'acide nucleique utilisant l'agglutination de particules Ceased WO1992004469A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9019512.4 1990-09-06
GB909019512A GB9019512D0 (en) 1990-09-06 1990-09-06 Assay method

Publications (2)

Publication Number Publication Date
WO1992004469A2 WO1992004469A2 (fr) 1992-03-19
WO1992004469A3 true WO1992004469A3 (fr) 1992-05-14

Family

ID=10681798

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1991/001517 Ceased WO1992004469A2 (fr) 1990-09-06 1991-09-06 Procede de detection d'acide nucleique utilisant l'agglutination de particules

Country Status (3)

Country Link
AU (1) AU8505091A (fr)
GB (1) GB9019512D0 (fr)
WO (1) WO1992004469A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115688B1 (en) 1998-11-30 2006-10-03 Nanosphere, Inc. Nanoparticles with polymer shells
US7135055B2 (en) 2001-05-25 2006-11-14 Nanosphere, Inc. Non-alloying core shell nanoparticles
US7147687B2 (en) 2001-05-25 2006-12-12 Nanosphere, Inc. Non-alloying core shell nanoparticles

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601978A (en) * 1993-09-03 1997-02-11 Abbott Laboratories Oligonucleotides and methods for the detection of chlamydia trachomatis
US5641658A (en) * 1994-08-03 1997-06-24 Mosaic Technologies, Inc. Method for performing amplification of nucleic acid with two primers bound to a single solid support
US6090592A (en) * 1994-08-03 2000-07-18 Mosaic Technologies, Inc. Method for performing amplification of nucleic acid on supports
US6060288A (en) * 1994-08-03 2000-05-09 Mosaic Technologies Method for performing amplification of nucleic acid on supports
US5747256A (en) * 1995-12-19 1998-05-05 Beckman Instruments, Inc. Homogeneous DNA probe titration assay
US6361944B1 (en) 1996-07-29 2002-03-26 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US7098320B1 (en) 1996-07-29 2006-08-29 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6506564B1 (en) 1996-07-29 2003-01-14 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6582921B2 (en) 1996-07-29 2003-06-24 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses thereof
US6984491B2 (en) 1996-07-29 2006-01-10 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
US6750016B2 (en) 1996-07-29 2004-06-15 Nanosphere, Inc. Nanoparticles having oligonucleotides attached thereto and uses therefor
AU6846698A (en) 1997-04-01 1998-10-22 Glaxo Group Limited Method of nucleic acid amplification
US6974669B2 (en) 2000-03-28 2005-12-13 Nanosphere, Inc. Bio-barcodes based on oligonucleotide-modified nanoparticles
WO1999023258A1 (fr) * 1997-10-31 1999-05-14 Gen-Probe Incorporated Procedes de detection d'acide nucleique
US6080544A (en) * 1998-02-13 2000-06-27 Ohio State University Methods for identifying nucleic acid mutations using mismatch modification
EP1198591B1 (fr) * 1999-06-25 2011-03-16 Nanosphere, Inc. Nanoparticules auxquelles sont rattaches des oligonucleotides et leurs utilisations
EP1294930B1 (fr) 2000-01-13 2011-03-30 Nanosphere, Inc. Nanoparticules auxquelles sont attaches des oligonucleotides et utilisations de ces dernieres
US6602669B2 (en) 2000-07-11 2003-08-05 Northwestern University Method of detection by enhancement of silver staining
US20030175994A1 (en) * 2000-10-05 2003-09-18 Yoram Palti Geometrically efficient particle agglutination, particularly to detect low affinity
AR031640A1 (es) 2000-12-08 2003-09-24 Applied Research Systems Amplificacion isotermica de acidos nucleicos en un soporte solido
WO2003081202A2 (fr) 2001-11-09 2003-10-02 Nanosphere, Inc. Sondes nanoparticulaires de bioconjugue
JP2005532456A (ja) 2002-07-02 2005-10-27 ナノスフェアー　インコーポレイテッド ナノ粒子ポリアニオン複合物ならびに分析物の検出における同複合物の用途
US8372648B2 (en) 2003-04-16 2013-02-12 APDN (B.V.I.), Inc. Optical reporter compositions
US8124333B2 (en) * 2003-04-16 2012-02-28 APDN, Inc. Methods for covalent linking of optical reporters
US10741034B2 (en) 2006-05-19 2020-08-11 Apdn (B.V.I.) Inc. Security system and method of marking an inventory item and/or person in the vicinity
WO2008093098A2 (fr) 2007-02-02 2008-08-07 Illumina Cambridge Limited Procedes pour indexer des echantillons et sequencer de multiples matrices nucleotidiques
WO2010038042A1 (fr) 2008-10-02 2010-04-08 Illumina Cambridge Ltd. Enrichissement d'échantillons d'acide nucléique pour des applications de séquençage
US8182994B2 (en) 2009-09-15 2012-05-22 Illumina Cambridge Limited Centroid markers for image analysis of high denisty clusters in complex polynucleotide sequencing
CA2926436A1 (fr) 2013-10-07 2015-04-16 Judith Murrah Lecteur multimode d'image et spectral
US10745825B2 (en) 2014-03-18 2020-08-18 Apdn (B.V.I.) Inc. Encrypted optical markers for security applications
CN106103121B (zh) 2014-03-18 2019-12-06 亚普蒂恩(B.V.I.)公司 用于安全应用的加密光学标记物
CN109070130B (zh) 2016-04-11 2022-03-22 亚普蒂恩（B V I）公司 用于标记纤维素产品的方法
US10995371B2 (en) 2016-10-13 2021-05-04 Apdn (B.V.I.) Inc. Composition and method of DNA marking elastomeric material
US10920274B2 (en) 2017-02-21 2021-02-16 Apdn (B.V.I.) Inc. Nucleic acid coated submicron particles for authentication

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005334A1 (fr) * 1986-03-04 1987-09-11 Angenics, Inc. Detection d'acides nucleiques par la determination de l'agglutination de particules
WO1990002205A1 (fr) * 1988-08-25 1990-03-08 Angenics, Inc. Detection de sequences d'acides nucleiques par agglutination de particules
EP0332435B1 (fr) * 1988-03-10 1992-04-22 Zeneca Limited Procédé pour détecter des séquences de nucléotides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005334A1 (fr) * 1986-03-04 1987-09-11 Angenics, Inc. Detection d'acides nucleiques par la determination de l'agglutination de particules
EP0332435B1 (fr) * 1988-03-10 1992-04-22 Zeneca Limited Procédé pour détecter des séquences de nucléotides
WO1990002205A1 (fr) * 1988-08-25 1990-03-08 Angenics, Inc. Detection de sequences d'acides nucleiques par agglutination de particules

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115688B1 (en) 1998-11-30 2006-10-03 Nanosphere, Inc. Nanoparticles with polymer shells
US7135055B2 (en) 2001-05-25 2006-11-14 Nanosphere, Inc. Non-alloying core shell nanoparticles
US7147687B2 (en) 2001-05-25 2006-12-12 Nanosphere, Inc. Non-alloying core shell nanoparticles
US7238472B2 (en) 2001-05-25 2007-07-03 Nanosphere, Inc. Non-alloying core shell nanoparticles

Also Published As

Publication number Publication date
GB9019512D0 (en) 1990-10-24
WO1992004469A2 (fr) 1992-03-19
AU8505091A (en) 1992-03-30

Similar Documents

Publication Publication Date Title
WO1992004469A3 (fr) Procede de detection d'acide nucleique utilisant l'agglutination de particules
DE69733488D1 (de) Verfahren zur besserung der wiederfindung troponin i und t
ATE281648T1 (de) Verfahren zum assay von troponin i und t und komplexen von troponin i und t und auswahl von antikörpern zur verwendung in immunoassays
ATE127231T1 (de) Verfahren zur bestimmung eines oder mehrerer analyte durch anwendung verschiedene typen von partikeln, welche durchflusszytometrisch unterschieden sind.
CA2218491A1 (fr) Nouveaux procedes de dosage de la troponine i et t et de ses complexes, et selection d'anticorps utilises dans des dosages immunologiques
DE3852117D1 (de) Immunoassay mit Verwendung von nichtmetallischen, kolloidalen Teilchen.
DE4309393A1 (de) Verringerung des Hook-Effekts in Immuntests mit teilchenförmigem Trägermaterial
JPS6447951A (en) Immunoassay method and kit for hapten detection by agglutination
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
DK0669000T3 (da) Dobbelt immunanalyse for et antistof med kemisk luminescerende og biotinbundet ligand
JPH02502942A (ja) 凝集による黄色ブドウ球菌の検出用試薬
EP0346119A3 (fr) Essai anti-FC pour détecter des anticorps
GB2260609B (en) Separation and analysis
ATE423971T1 (de) Immunologisches verfahren
CA2303123A1 (fr) Procede pour detecter des anticorps dans un echantillon
DE68922126D1 (de) Immunometrisches Verfahren zum Nachweis von Lipoprotein-Teilchen, anti-Lp(a) Monoklonale Antikörper und ihre Anwendung zur Diagnose von Atherosklerose.
EP0242589A3 (fr) Détection d'haptènes dans des techniques d'immunoessai
ATE220098T1 (de) Eine petroleum immuntestmethode und ihre komponenten
HK1040112A1 (zh) 在液体样本中检测和/或定量特异ige抗体的方法
ATE111226T1 (de) Verfahren zum nachweis von analyten.
Galanti et al. Immunoassay of hepatitis B surface antigen by particle counting after pepsin digestion
EP0096520A3 (fr) Détermination d'antigène:Arthrite rhumatique
CA2088471A1 (fr) Methode de determination des facteurs rhumatoides et agents requis pour utiliser la methode
EP0328372A3 (fr) Procédé pour la détermination d'antigènes
DE69533200D1 (de) Verfahren zur prüfung von immunokompetenz

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MC MG MN MW NO PL RO SD SU US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU ML MR NL SE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MC MG MN MW NO PL RO SD SU US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU ML MR NL SE SN TD TG

NENP Non-entry into the national phase

Ref country code: CA